Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson’s disease brains with Lewy body pathology
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1701, 75-84
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health, NIA
This publication has 58 references indexed in Scilit:
- Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesNeurobiology of Disease, 2013
- Autophagy modulation as a potential therapeutic target for diverse diseasesNature Reviews Drug Discovery, 2012
- Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's diseaseEMBO Molecular Medicine, 2012
- Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial AutophagyJournal of Biological Chemistry, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- α-Synuclein impairs macroautophagy: implications for Parkinson’s diseaseJournal of Cell Biology, 2010
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged miceProceedings of the National Academy of Sciences, 2010
- The role of the Atg1/ULK1 complex in autophagy regulationCurrent Opinion in Cell Biology, 2010
- Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal CellsJournal of Biological Chemistry, 2008
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001